# Alkem Laboratories completes acquisition of 51-55% stake in Occlutech Holding AG

Alkem Laboratories, through its wholly owned subsidiary Alkem Medtech Private Limited, has completed the acquisition of a 51-55% stake in Swiss medical device manufacturer Occlutech Holding AG. The transaction was funded by a ₹1,100 crore capital infusion into Alkem Medtech.

- Type: Acquisition
- Announced: 2026-07-17
- Where: Switzerland
- Value: $132.0M (11.0B INR)
- Status: completed
- Products: medical devices for cardiovascular and orthopedic fields
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alkem Laboratories](https://endata.com/companies/74928.md) (acquirer)
- [Alkem MedTech Pvt Ltd](https://endata.com/companies/79365.md) (acquirer)
- [Occlutech Holding AG](https://endata.com/companies/90359.md) (target)

## Sources

- [scanx.trade](https://scanx.trade/stock-market-news/companies/alkem-laboratories-acquires-alkem-medtech-shares-for-1-100-crore/45830023), 2026-07-17: "Alkem Laboratories announced that its wholly owned subsidiary, Alkem Medtech Private Limited, has completed the acquisition of at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.